Arete Therapeutics News
Most Popular Arete Therapeutics Story
Tengion raises $21M for second close of Series C
The doom and gloom talk, though, doesn't mean that the money spigot is closed. Tengion announced today that it raised $21 million in a second close of its Series C. But its CEO says its success at... Read more...
Latest Headlines
- December 1, 2008
- November 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
